Skip to main content
Adriana Kahn, MD, Oncology, New Haven, CT

AdrianaMatutinoKahnMD

Oncology New Haven, CT

Breast Cancer

Assistant Professor of Medicine (Medical Oncology)

Dr. Kahn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kahn's full profile

Already have an account?

  • Office

    35 Park St
    New Haven, CT 06511

Education & Training

  • University of Connecticut
    University of ConnecticutResidency, Internal Medicine, 2018 - 2021
  • Federal University of Bahia Faculty of Medicine
    Federal University of Bahia Faculty of MedicineClass of 2010

Certifications & Licensure

  • CT State Medical License
    CT State Medical License 2018 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Merit Award Recipient, Cancer Survivorship Symposium ASCO, 2018
  • Laureate Award fora Medical Student Federal University of Bahia School of Medicine, 2011
  • Honorable Mention, Poster UFBA, 2008
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Clinical impact of adjuvant radiotherapy delay after neoadjuvant chemotherapy inlocally advanced breast cancer  
    Brito S, Pereira AA, Medeiros KA, Brasileiro VJ, Matutino, A, Leonardi MCA, Velame R, Viveiros PH, Lima J, Filassi D, Carvalho H,Piato JR, Mano,MS, Breast, 1/1/2018
  • Prophylactic cranial irradiation for extensive stage small cell lung cancer � a retrospective analysis  
    Matutino ARB, Mak MP, Takahashi TK, Fraile NMP, Bitton RC, Nakazato D, Guimaraes RGR, Gabrielli FCG, Vasconcelos KGMC, Carvalho HA, Castro-Junior G, Journal of Global Oncology, 1/1/2017
  • Safety and Efficacy of a Modified FLOX Adjuvant Regimenfor Patients With Stage III Colorectal Cancer Treated in the Community  
    Protasio BM, MatutinoA, Lage LV, SantanaI,Ramos R,Sabbaga J,CapareliF,SaragiottoD, RiechelmannR,HoffPM, ClinColorectal Cancer, 1/1/2016
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Lymphoma-Associated Pulmonary Embolism Burden in Hospital Admissions in the United States
    Adriana Kahn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • The impact of age in the quality of life of patients diagnosed with breast cancer after curative treatment.
    Matutino A, Lewis J, HuberS, TaylorA, ChenG, Verma S, ASCO Cancer Survivorship Symposium: Advancing Care and Research, 1/1/2018
  • Complete Pathologic Response as a Prognostic Factor in Breast Cancer: The Experience of a Brazilian Cancer Reference Center.
    MatutinoARB, Lima JMS, Silva SB, Silva-JuniorAA,Fraile NMP,Boas,MSV,StephanBO, Vaisberg VV, Pereira AAL, Mano MS, Clinical Oncology Brazilian Society Meeting, 1/1/2015
  • Join now to see all

Lectures

  • Clinical characteristics and survival of lung cancer patients according to insurance status prior to and post the implementation of the Affordable Care Act. 
    Atlanta, GA - 1/1/2018
  • Survivorship Care in Breast Cancer: Transitioning from Cancer Centres to Family Physicians. 
    Calgary, Canada - 1/1/2017
  • Crizotinib for advanced non-small cell lung cancer patients with ALK and ROS1 rearrangements: a 4-year Canadian center experience. 
    Calgary, Canada, 2017; Atlanta, GA, 2017 - 1/1/2017
  • Join now to see all

Press Mentions

  • Study: Patient’s Genetic Characteristics May Help Differentiate HER2-Low Advanced Breast Cancers and Guide Treatment Selection
    Study: Patient’s Genetic Characteristics May Help Differentiate HER2-Low Advanced Breast Cancers and Guide Treatment SelectionDecember 9th, 2023
  • Yale Cancer Center Experts Present New Research at Leading Breast Cancer Symposium
    Yale Cancer Center Experts Present New Research at Leading Breast Cancer SymposiumDecember 20th, 2023
  • Breast Cancer Highlights from ASCO 2024
    Breast Cancer Highlights from ASCO 2024June 19th, 2024